3.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDY

Aim: Type 2 diabetes (DM2) causes microvascular dysfunction (MVD). In addition, MVD can contribute to insulin resistance, predisposing to DM2. This hypothesis predicts that MVD should be present in impaired glucose metabolism (IGM; prediabetes). However, population-based studies of MVD and glucose m...

Full description

Bibliographic Details
Main Authors: Ben Sörensen*, Boy Houben, Tos Berendschot, Jan Schouten, Bram Kroon, Carla van der Kallen, Ronald Henry, Annemarie Koster, Pieter Dagnelie, Nicolaas Schaper, Miranda Schram, Coen Stehouwer
Format: Article
Language:English
Published: Atlantis Press 2015-11-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125930713/view
id doaj-95a6baa2ec894ef4994aa4836d9cac1a
record_format Article
spelling doaj-95a6baa2ec894ef4994aa4836d9cac1a2020-11-25T03:01:46ZengAtlantis PressArtery Research 1876-44012015-11-011210.1016/j.artres.2015.10.0143.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDYBen Sörensen*Boy HoubenTos BerendschotJan SchoutenBram KroonCarla van der KallenRonald HenryAnnemarie KosterPieter DagnelieNicolaas SchaperMiranda SchramCoen StehouwerAim: Type 2 diabetes (DM2) causes microvascular dysfunction (MVD). In addition, MVD can contribute to insulin resistance, predisposing to DM2. This hypothesis predicts that MVD should be present in impaired glucose metabolism (IGM; prediabetes). However, population-based studies of MVD and glucose metabolism are not available. We investigated this using the retinal arteriolar dilator response to flicker light. Methods: In a population-based study (n = 2205), we determined retinal %-dilation (Dynamic Vessel Analyzer; Imedos, Germany) and glucose metabolism status (OGTT; classified as normal (NGM), IGM or DM2). Differences were compared with multivariable regression adjusted for age, sex, BMI, smoking, systolic-BP, lipid profile, retinopathy, (micro)albuminuria, the use of lipid-modifying and/or blood-pressure-lowering medication and prior cardiovascular disease. Results: 1263 individuals had NGM (42% men, aged 58 ± 8 years (mean ± SD)), 336 IGM (61% men, aged 61 ± 7 years) and 606 (due to oversampling) DM2 (69% men, aged 63 ± 8 years). Arteriolar %-dilation was median 3.51, IQR 1.47 to 5.95, range −5.69 to +19.71. %-dilation (mean ± SD) was 4.42 ± 3.45 in NGM, 3.77 ± 3.06 in IGM, and 3.26 ± 3.27 in DM2. Adjusted analyses showed decreased %-dilation in IGM (β = −0.461, p = 0.03) and DM2 (β = 0.559, p = 0.01) vs NGM. Conclusion: IGM and DM2 are associated with reduced flicker-light-induced retinal arteriolar dilation, independently of major cardiovascular risk factors. These findings support the concept that MVD precedes and thus may contribute to DM2.https://www.atlantis-press.com/article/125930713/view
collection DOAJ
language English
format Article
sources DOAJ
author Ben Sörensen*
Boy Houben
Tos Berendschot
Jan Schouten
Bram Kroon
Carla van der Kallen
Ronald Henry
Annemarie Koster
Pieter Dagnelie
Nicolaas Schaper
Miranda Schram
Coen Stehouwer
spellingShingle Ben Sörensen*
Boy Houben
Tos Berendschot
Jan Schouten
Bram Kroon
Carla van der Kallen
Ronald Henry
Annemarie Koster
Pieter Dagnelie
Nicolaas Schaper
Miranda Schram
Coen Stehouwer
3.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDY
Artery Research
author_facet Ben Sörensen*
Boy Houben
Tos Berendschot
Jan Schouten
Bram Kroon
Carla van der Kallen
Ronald Henry
Annemarie Koster
Pieter Dagnelie
Nicolaas Schaper
Miranda Schram
Coen Stehouwer
author_sort Ben Sörensen*
title 3.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDY
title_short 3.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDY
title_full 3.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDY
title_fullStr 3.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDY
title_full_unstemmed 3.1 PREDIABETES IS ASSOCIATED WITH IMPAIRED RETINAL VASODILATION: THE MAASTRICHT STUDY
title_sort 3.1 prediabetes is associated with impaired retinal vasodilation: the maastricht study
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2015-11-01
description Aim: Type 2 diabetes (DM2) causes microvascular dysfunction (MVD). In addition, MVD can contribute to insulin resistance, predisposing to DM2. This hypothesis predicts that MVD should be present in impaired glucose metabolism (IGM; prediabetes). However, population-based studies of MVD and glucose metabolism are not available. We investigated this using the retinal arteriolar dilator response to flicker light. Methods: In a population-based study (n = 2205), we determined retinal %-dilation (Dynamic Vessel Analyzer; Imedos, Germany) and glucose metabolism status (OGTT; classified as normal (NGM), IGM or DM2). Differences were compared with multivariable regression adjusted for age, sex, BMI, smoking, systolic-BP, lipid profile, retinopathy, (micro)albuminuria, the use of lipid-modifying and/or blood-pressure-lowering medication and prior cardiovascular disease. Results: 1263 individuals had NGM (42% men, aged 58 ± 8 years (mean ± SD)), 336 IGM (61% men, aged 61 ± 7 years) and 606 (due to oversampling) DM2 (69% men, aged 63 ± 8 years). Arteriolar %-dilation was median 3.51, IQR 1.47 to 5.95, range −5.69 to +19.71. %-dilation (mean ± SD) was 4.42 ± 3.45 in NGM, 3.77 ± 3.06 in IGM, and 3.26 ± 3.27 in DM2. Adjusted analyses showed decreased %-dilation in IGM (β = −0.461, p = 0.03) and DM2 (β = 0.559, p = 0.01) vs NGM. Conclusion: IGM and DM2 are associated with reduced flicker-light-induced retinal arteriolar dilation, independently of major cardiovascular risk factors. These findings support the concept that MVD precedes and thus may contribute to DM2.
url https://www.atlantis-press.com/article/125930713/view
work_keys_str_mv AT bensorensen 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT boyhouben 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT tosberendschot 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT janschouten 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT bramkroon 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT carlavanderkallen 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT ronaldhenry 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT annemariekoster 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT pieterdagnelie 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT nicolaasschaper 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT mirandaschram 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
AT coenstehouwer 31prediabetesisassociatedwithimpairedretinalvasodilationthemaastrichtstudy
_version_ 1724692097331625984